GLP-1 Drugs May Improve Breast Cancer Survival, Lower Risk of Recurrence

A recent study found that GLP-1 medications like Ozempic and Wegovy may help improve breast cancer survival rates among women with obesity and type 2 diabetes.

May 15, 2026   TODAY’S TOP STORY GLP-1 Drugs May Improve Breast Cancer Survival, Lower Risk of Recurrence READ ON   PCOS Is Now PMOS: Doctors Say Name Change Will Improve Diagnosis, Care READ ON   8,500 Daily Steps Can Help You Lose Weight and Keep It Off READ ON   Ask the Expert: Can Peyronie’s Disease Treatments Cure Erectile Dysfunction? READ ON MORE STORIES PRODUCT PICK Buy It For Life (BIFL): Vetted Products Guaranteed to Last   Stop replacing what you buy. We cut through the chatter to bring you our vetted picks for "Buy It For Life" products guaranteed to save you money. SHOP NOW TODAY'S RESOURCE Eat Well Newsletter   Get recipes tailored to your unique tastes and interests every month! SIGN UP NOW What we’re reading next • Why You're Sleeping Through Your Alarm – and How to Stop Hitting the Snooze Button Once and for All • How to Find Yourself Again After a Breakup • I Ran the Boston Marathon: Here's What I Learned About Resilience on And Off the Track • A Beginner’s Guide to Vaginal Fisting We'd love to hear from you! Send us a message at newsletters@healthline.com to let us know what else you’d like to see. Until then, Take care of yourself, and we’ll see you again soon! View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy   |   Unsubscribe We may feature your messages to our inbox within our content. Please do not provide any personal identifiable information. Replies may be edited for length and clarity. For more, see our Privacy Policy. Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Every product we recommend has gone through either Healthline’s or Optum Now’s vetting processes. If you buy through links on this page, we may receive a small commission or other tangible benefit. Healthline has sole editorial control over this newsletter. Potential uses for the products listed here are not health claims made by the manufacturers. Healthline and Optum Now are owned by RVO Health. © 2026 RVO Health 1101 Red Ventures Drive Fort Mill, SC 29707